Nayzilam FDA Approval History
FDA Approved: Yes (First approved May 17, 2019)
Brand name: Nayzilam
Generic name: midazolam
Dosage form: Nasal Spray
Company: UCB, Inc.
Treatment for: Seizure Clusters
Nayzilam (midazolam) is a nasally administered benzodiazepine indicated for the acute treatment of seizure clusters.
Development Timeline for Nayzilam
|May 20, 2019||FDA Approves Nayzilam (midazolam) Nasal Spray to Treat Seizure Clusters|
|Aug 13, 2018||FDA Accepts New Drug Application (NDA) to Review Midazolam Nasal Spray, an Investigational Product for the Acute Treatment of Seizure Clusters|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.